Background Anaplastic Lymphoma Kinase (ALK) positivity represents a novel molecular target inside a subset of Non-Small Cell Lung Cancers (NSCLC). cells available, 5 had been positive for ALK IHC and 1 adverse. Conclusions ALK positive individuals stand for 7.1% of the human population of chosen NSCLC. ALK positive individuals possess different clinical features and an… Continue reading Background Anaplastic Lymphoma Kinase (ALK) positivity represents a novel molecular target